% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Katzke:153922,
author = {V. Katzke$^*$ and T. Johnson$^*$ and D. Sookthai$^*$ and A.
Hüsing$^*$ and T. Kühn$^*$ and R. Kaaks$^*$},
title = {{C}irculating liver enzymes and risks of chronic diseases
and mortality in the prospective {EPIC}-{H}eidelberg
case-cohort study.},
journal = {BMJ open},
volume = {10},
number = {3},
issn = {2044-6055},
address = {London},
publisher = {BMJ Publishing Group},
reportid = {DKFZ-2020-00532},
pages = {e033532},
year = {2020},
note = {#EA:C020#LA:C020#},
abstract = {Elevated liver enzyme concentrations in blood are
indicative of liver diseases and may provide an early signal
for being at risk for other chronic diseases. Our study
aimed to assess the relationships of alkaline phosphatase
(ALP), gamma-glutamyltransferase (GGT), alanine
aminotransferase (ALT), aspartate transaminase (AST) and the
De Ritis ratio (AST/ALT) with incidence and mortality of
cardiovascular diseases (CVD) and the four most common
cancers, that is, breast, prostate, colorectal and lung.We
analysed a case-cohort sample of the prospective European
Prospective Investigation into Cancer and
Nutrition-Heidelberg cohort, including cancer (n=1632),
cancer mortality (n=761), CVD (n=1070), CVD mortality
(n=381) and a random subcohort (n=2739) with an average
follow-up duration of 15.6 years. Concentrations of liver
enzymes were measured in prediagnostic blood samples and
Prentice-weighted Cox regression models were used to
estimate HRs with $95\%$ CIs.High ALP levels were associated
with increased risk for lung cancer and all-cause mortality
(highest vs lowest quartile, multivariable adjusted HR=2.39
$(95\%$ CI 1.30 to 4.39), HR=1.31 $(95\%$ CI 1.02 to 1.67)),
high AST levels with all-cause mortality (HR=1.45 $(95\%$ CI
1.15 to 1.82)), and a high De Ritis ratio with prostate
cancer risk, all-cause and cancer mortality (HR=1.61 $(95\%$
CI 1.10 to 2.36), HR=1.60 $(95\%$ CI 1.25 to 2.04), HR=1.67
$(95\%$ CI 1.26 to 2.23)). Using cut-points for liver enzyme
levels above normal, we observed positive associations for
all-cause mortality with ALP, GGT and AST, and assigning a
combined risk score resulted in positive associations with
all-cause and cause-specific mortality.Measurements of serum
liver enzymes, as routinely performed in health check-ups,
may support the identification of individuals at increased
risk for all-cause mortality. Further prospective studies
are needed to verify our first results on individual cancers
and on a combined risk score.},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32152162},
doi = {10.1136/bmjopen-2019-033532},
url = {https://inrepo02.dkfz.de/record/153922},
}